Your Cart ( 1 Item )

• Winning Poster: A Phase 2, Open-Label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects with Recalcitrant Contact or Atopic Dermatitis
  August 2011 | Volume 10 | Issue 8 | Features | 928 | Copyright © August 2011
  Eva Volf MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs